Yecuris FRG: Liver-Humanized Mice & Preclinical Research Services
  • FRG® PLATFORM
    • Platform Overview
    • FRG® KO Mice
    • Fresh Hepatocytes
    • HBVgo™ Hepatocytes
    • Reagents
  • APPLICATION AREAS
    • Gene Editing & Gene Therapy
    • NASH & NAFLD
    • Infectious Diseases
    • DMPK
    • All Case Studies
  • SERVICES
    • Research Services
    • Custom Transplantation
  • OUR COMPANY
    • About Us
    • Publications
    • Careers
  • CONTACT US
Select Page
FRGN mice repopulated with a hemophilia B donor

FRGN mice repopulated with a hemophilia B donor

by Zoe Dimond | May 6, 2026

GalNac-siRNA knowndown of human C5 in liver-humanized mice

GalNac-siRNA knowndown of human C5 in liver-humanized mice

by Zoe Dimond | May 6, 2026

Cholesterol lipoprotein metabolism & LXR-agonist PD in humanized FRG mice

Cholesterol lipoprotein metabolism & LXR-agonist PD in humanized FRG mice

by Yecuris Corporation | Dec 24, 2019

New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Minniti et. al., 2019 Study Summary Minniti ME, Pedrelli M, Vedin LL, Delbès AS, Denis RGP, Öörni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi HJ,...
Yecuris Corporation | P.O. Box 4645, Tualatin, OR 97062 | 503.352.4663     Privacy Policy    Terms & Conditions
©2026 Yecuris Corporation. All rights reserved. Yecuris™, FRG®, MetAbArray™, HepaCur™ and CuRx™ are trademarks of Yecuris Corporation.